QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.

QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client's small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full-service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.

In our catalog and on our web site, we offer over 1,500 monoclonal and polyclonal antibodies for research, discovery, and diagnostic applications in cancer research, neuroscience, signal transduction, infectious disease, and many other research areas. Our capabilities in antibody production allow us to offer only the highest quality antibodies. Although not required, QED has opted to manufacture all products under conditions of cGMP to provide the best possible level of manufacturing control and product reliability.

Building upon our experience in the antibody development and manufacturing field, QED is continuing to develop new antibody products and immunological services to better serve our clients and support their research efforts.